Subscribe to Our Weekly Newsletter

Justice & The Courts

Attorney General Paxton Secures $7.5M Settlement From Tris Pharma Over ADHD Drug Marketing

Texas Attorney General Ken Paxton has secured a $7.5 million settlement with Tris Pharmaceuticals, known as Tris Pharma, over claims about the effectiveness of Dyanavel XR, an attention-deficit/hyperactivity disorder (ADHD) drug marketed for children, according to an Oct. 1 news release from the Office of the Attorney General.

The Texas Dispatch · Oct 2, 2026